| INTRODUCTION
Biliary atresia (BA) is a neonatal disease characterized by fibrotic obliteration of the extrahepatic bile duct and intrahepatic periductal inflammation and injury, eventually resulting in cirrhosis. It is reported that the incidence of BA in Europe and the United States is about 0.6~0.8/10 000 while in Asia country such as Japan is 0.8~1.1/10 000. 1 Kasai is the first choice for the treatment which aims at restoring bile drainage and improving the situation of cholestasis.
However, due to progressive liver fibrosis, cholestatic cirrhosis, and portal hypertension, the majority of BA children eventually need to choose liver transplant as the ultimate treatment, 2 only less than 18%
of BA children can avoid liver transplantation.
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The etiology of BA is still uncertain which may be related to gene defect, 4 virus infection, 5 immune disorder, 6 gene polymorphism, 7 but each theory can only explain some of the cases of BA.
So far, genetic risk factors have been considered to play an important role in the pathogenesis of BA. Genome-wide association study (GWAS), as the main tool of human genetics research, has been widely used in the study of many complicated diseases 8 
| MATERIALS AND METHODS

| Study subjects
A total of 1979 Chinese subjects were included in the present study. 
| Polymorphism analysis
Genomic DNA was mainly extracted from 2 mL of peripheral blood sample using the TIANamp Blood DNA Kit (TianGen Biotech Co.
Ltd., Beijing, China) following the manufacturer's instructions. DNA concentration and purity were determined by spectrophotometric measurement of absorbance at 260 and 280 nm by a UV spectrophotometer (Nano Drop Technologies, Inc., Wilmington, DE).
Briefly, qualified DNA samples were diluted to 10 ng/μL and loaded in 96-well plates. Then, the VEGFA gene SNP (rs3025039 T/C) was successfully designed on a customized multiplex genotyping panel using the MassARRAY iPLEX Gold system (Sequenom).
Significant deviation from Hardy-Weinberg equilibrium in controls
and all passed the test with P-value >.05 (P = .874). To ensure the accuracy of genotyping results, four positive controls and four negative controls were included in each of the 384-well plates. The assays were repeated for 5% of the samples, and the results were 100%
concordant.
| Statistical analysis
We used χ 2 test to evaluate the differences in the frequency distributions of the demographics and genotypes between the BA cases and the controls. PLINK software was used to verify the relationship between the VEGFA gene polymorphism (rs3025039) and BA risk.
Odds ratios (ORs) and 95% confidence intervals (CIs) were used to assess the correlations between the VEGFA gene SNP (rs3025039 T/C) and BA susceptibility. P value <.05 was considered as statistically significant. Linkage disequilibrium (LD) patterns and values were obtained using Haploview. 16 Association of the SNPs with disease risk was also corrected by logistic regression using age and sex as covariates and the associations found in this study remain significant after all the corrections. Association with subphenotype was analyzed by comparing cases with a certain subphenotype, cases without the subphenotype with controls and healthy controls. Heterogeneity test of three ORs was compared among the cases with and without the subphenotypes.
| RESULTS
| Population characteristics
The demographic characteristics of participants are reviewed in Table   S1 . Regarding subphenotype of BA, 44(8.7%) were cystic biliary atresia (CBA) patients and 462(91.3%) were non-CBA subjects.
| The replication results of SNP rs3025039 in VEGFA in a southern Chinese population
In this study, 506 cases and 1473 controls were successfully genotype.
The replication results of VEGFA gene SNP (rs3025039) is shown in Table 1 . We found that there is no significant association between rs3025039 T/C polymorphism and BA susceptibility (P = .62).
We utilized different genetic models to verify the feasibility of the result. The detailed replication results are shown in Table 2 . There is no significant association between VEGFA gene SNP (rs3025039) and BA susceptibility in GENO model (P = .88). Similar results were found in TREND model, DOM model and REC model (P = .62, P = .66, P = .73, respectively).
| The results of VEGFA gene SNP (rs3025039) and BA subphenotype
Based on the results of previous studies, the cystic biliary atresia (CBA) has a better clinical outcome after a hepaticojejunostomy. 17 In this context, we explore the relationship between VEGFA gene SNP (rs3025039) and BA subphenotype (including 44cases of CBA and 462 non-CBA subjects). All CBA patients were confirmed by cholangiography. However, we found no significant association between the polymorphism of VEGFA gene and BA subphenotype. The detailed results are shown in Table 3 .
| DISCUSSION
In this study, we investigated whether VEGFA gene SNP (rs3025039) was associated with the risk of BA in southern Chinese Han children.
To our disappointment, we found no significant association between rs3025039 T/C polymorphism and BA susceptibility. These findings suggest the VEGFA gene +936 SNP does not play an important role in BA predisposition in southern Chinese Han children.
Although the etiology and pathogenesis of BA is still not clear, induction and maintenance of systemic and local inflammatory responses are considered to be an important factor. 18 Cytokines play an OR, odds ratio; CI, confidence interval; F-A means of the minor allele (T) frequency in BA subphenotype (CBA or non-CBA) group; F-U means the minor allele (T) frequency in normal control group.
T A B L E 3
The results of VEGFA gene SNP (rs3025039) and BA subphenotype the control group, the serum VEGF level in acute cholangitis stage was significantly increased, indicating that VEGF was involved in the occurrence of BA.
